These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6538355)

  • 1. Effect of selective inhibitor of thromboxane A2 synthetase on experimental cerebral vasospasm.
    Fukumori T; Tani E; Maeda Y; Sukenaga A
    Stroke; 1984; 15(2):306-11. PubMed ID: 6538355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin and thromboxane in cerebral vasospasm II: Effects of thromboxane synthetase inhibitor (OKY-1581) on experimentally-induced cerebral vasospasm.
    Yabuno N
    Acta Med Okayama; 1984 Jun; 38(3):239-50. PubMed ID: 6380217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm.
    Toshima Y; Satoh S; Ikegaki I; Asano T; Suzuki Y; Shibuya M
    Life Sci; 1997; 61(14):1371-7. PubMed ID: 9335226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of OKY-046, a selective thromboxane A2 synthetase inhibitor, on experimental cerebral vasospasm.
    Komatsu H; Takehana Y; Hamano S; Ujiie A; Hiraku S
    Jpn J Pharmacol; 1986 Jul; 41(3):381-91. PubMed ID: 3761754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
    Sasaki T; Wakai S; Asano T; Takakura K; Sano K
    J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-lipoxygenase inhibitor on experimental delayed cerebral vasospasm.
    Yokota M; Tani E; Maeda Y; Kokubu K
    Stroke; 1987; 18(2):512-8. PubMed ID: 3564111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets.
    Naito J; Komatsu H; Ujiie A; Hamano S; Kubota T; Tsuboshima M
    Eur J Pharmacol; 1983 Jul; 91(1):41-8. PubMed ID: 6413227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery.
    Tani E; Maeda Y; Fukumori T; Nakano M; Kochi N; Morimura T; Yokota M; Matsumoto T
    J Neurosurg; 1984 Jul; 61(1):24-9. PubMed ID: 6539367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subarachnoid hemorrhage and a thromboxane A2 synthetase inhibitor on intracranial prostaglandins.
    Yokota M; Tani E; Fukumori T; Maeda Y; Yamaura I
    Surg Neurol; 1991 May; 35(5):345-9. PubMed ID: 2028380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thromboxane synthetase inhibitors on cyclical reduction of coronary blood flow in dogs.
    Uchida Y; Murao S
    Jpn Heart J; 1981 Nov; 22(6):971-5. PubMed ID: 7040725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin and thromboxane in cerebral vasospasm: effects of prostacyclin on experimentally-induced cerebral vasospasm.
    Yabuno N
    Acta Med Okayama; 1984 Apr; 38(2):147-58. PubMed ID: 6375270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm.
    Takeuchi H; Tanabe M; Okamoto H; Yamazaki M
    Neurol Res; 1999 Jul; 21(5):513-6. PubMed ID: 10439434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin metabolism in experimental cerebral vasospasm.
    Maeda Y; Tani E; Miyamoto T
    J Neurosurg; 1981 Nov; 55(5):779-85. PubMed ID: 7310500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
    Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
    Okamoto S; Yonekawa Y; Handa H; Handa Y; Uemura Y; Yano I; Toyoshima M; Iwatsuji K; Teraura T; Yamagata S
    Nihon Geka Hokan; 1986 Jan; 55(1):251-9. PubMed ID: 3741043
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
    Shea MJ; Driscoll EM; Romson JL; Pitt B; Lucchesi BR
    Eur J Pharmacol; 1984 Oct; 105(3-4):285-91. PubMed ID: 6542526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy.
    Yano K; Kuroda T; Tanabe Y; Yamada H
    Acta Neurochir (Wien); 1993; 125(1-4):15-9. PubMed ID: 8122540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.